In GBM, TGFβ suppresses anti-tumor immune cells (e.g., T cells, dendritic cells) and promotes pro-tumor immune cells (e.g., tumor-associated macrophages, microglia, and regulatory T cells) [15]. This evidence concerns the gene TGFB1 and neoplasm.